ADVB
Advanced Biomed, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.30
−12.88%Margins
Gross margin
-3856.4%
EBITDA margin
-5052.5%
EBIT margin
-4984.9%
Net margin
5231.3%
FCF margin
-954.7%
54.4%
Return on equity
48.6%
Return on assets
-49.4%
Return on invested capital
0.01x
Asset turnover
-$1.2M
Cash from operations
$0.23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026